Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

CALMETTES

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Science Advances|August 19, 2021
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infectionNader Yatim, Jeremy Boussier, Pauline Tetu, et al.
Science Immunology|March 20, 2026
Macrophages restrict tumor immune infiltration by controlling collagen topographyZoé Fusilier, Alexandra Clément, Franck Simon, et al.
Leukemia|June 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patientsOlivier Mansier, Eric Lippert, Lina Benajiba, et al.
Nature Immunology|June 4, 2024
Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodesZahraa Alraies, Claudia A Rivera, Maria-Graciela Delgado, et al.
Bulletin Du Cancer|September 12, 2024
[Nurturing and growing a community of department heads: Act 2 in haematology]Roch Houot, Claire Calmettes, Sophie Park, et al.
The Lancet. Oncology|October 2, 2025
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trialSalomon Manier, Jérôme Lambert, Cyrille Hulin, et al.
Nature Biotechnology|November 28, 2017
Global landscape of cell envelope protein complexes in Escherichia coliMohan Babu, Cedoljub Bundalovic-Torma, Charles Calmettes, et al.
Blood|September 24, 2025
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencingAnaïs Schavgoulidze, Aurore Perrot, Xavier Leleu, et al.
Nature Medicine|June 3, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trialXavier Leleu, Cyrille Hulin, Jerome Lambert, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Science Advances|August 19, 2021
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infectionNader Yatim, Jeremy Boussier, Pauline Tetu, et al.
Science Immunology|March 20, 2026
Macrophages restrict tumor immune infiltration by controlling collagen topographyZoé Fusilier, Alexandra Clément, Franck Simon, et al.
Leukemia|June 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patientsOlivier Mansier, Eric Lippert, Lina Benajiba, et al.
Nature Immunology|June 4, 2024
Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodesZahraa Alraies, Claudia A Rivera, Maria-Graciela Delgado, et al.
Bulletin Du Cancer|September 12, 2024
[Nurturing and growing a community of department heads: Act 2 in haematology]Roch Houot, Claire Calmettes, Sophie Park, et al.
The Lancet. Oncology|October 2, 2025
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trialSalomon Manier, Jérôme Lambert, Cyrille Hulin, et al.
Nature Biotechnology|November 28, 2017
Global landscape of cell envelope protein complexes in Escherichia coliMohan Babu, Cedoljub Bundalovic-Torma, Charles Calmettes, et al.
Blood|September 24, 2025
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencingAnaïs Schavgoulidze, Aurore Perrot, Xavier Leleu, et al.
Nature Medicine|June 3, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trialXavier Leleu, Cyrille Hulin, Jerome Lambert, et al.
Pageof 17